ENGINEERED BOTULINUM NEUROTOXIN

Disclosed herein are botulinum neurotoxin (BoNT) polypeptides with a modified receptor binding domain of Clostridial botulinum serotype B (B-Hc), comprising one or more substitution mutations corresponding to substitution mutations in serotype B, strain 1, V1118M; Y1183M; E1191M; E1191I; E1191Q; E11...

Full description

Saved in:
Bibliographic Details
Main Authors Dong Min, Peng Lisheng, Stenmark Pål Erik Gustav, Berntsson Ronnie Per Arne
Format Patent
LanguageEnglish
Published 10.08.2017
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

Abstract Disclosed herein are botulinum neurotoxin (BoNT) polypeptides with a modified receptor binding domain of Clostridial botulinum serotype B (B-Hc), comprising one or more substitution mutations corresponding to substitution mutations in serotype B, strain 1, V1118M; Y1183M; E1191M; E1191I; E1191Q; E1191T; S1199Y; S1199F; S1199L; S1201V; or combinations thereof. Specific combination mutations include E1191M and S1199L, E1191M and S1199Y, E1191M and S1199F, E1191Q and S1199L, E1191Q and S1199Y, or E1191Q and S1199F. Other substitution mutations are also disclosed. Isolated modified receptor binding domains, chimeric molecules, pharmaceutical compositions, and methods of using the same are also disclosed.
AbstractList Disclosed herein are botulinum neurotoxin (BoNT) polypeptides with a modified receptor binding domain of Clostridial botulinum serotype B (B-Hc), comprising one or more substitution mutations corresponding to substitution mutations in serotype B, strain 1, V1118M; Y1183M; E1191M; E1191I; E1191Q; E1191T; S1199Y; S1199F; S1199L; S1201V; or combinations thereof. Specific combination mutations include E1191M and S1199L, E1191M and S1199Y, E1191M and S1199F, E1191Q and S1199L, E1191Q and S1199Y, or E1191Q and S1199F. Other substitution mutations are also disclosed. Isolated modified receptor binding domains, chimeric molecules, pharmaceutical compositions, and methods of using the same are also disclosed.
Author Stenmark Pål Erik Gustav
Dong Min
Peng Lisheng
Berntsson Ronnie Per Arne
Author_xml – fullname: Dong Min
– fullname: Peng Lisheng
– fullname: Stenmark Pål Erik Gustav
– fullname: Berntsson Ronnie Per Arne
BookMark eNrjYmDJy89L5WSQd_Vz9_RzdQ1ydVFw8g8J9fH0C_VV8HMNDfIP8Y_w9ONhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGhuZGRmYmlmaOhsbEqQIAX-kktg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2017226496A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2017226496A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:00:26 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2017226496A13
Notes Application Number: US201715431694
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170810&DB=EPODOC&CC=US&NR=2017226496A1
ParticipantIDs epo_espacenet_US2017226496A1
PublicationCentury 2000
PublicationDate 20170810
PublicationDateYYYYMMDD 2017-08-10
PublicationDate_xml – month: 08
  year: 2017
  text: 20170810
  day: 10
PublicationDecade 2010
PublicationYear 2017
RelatedCompanies President and Fellows of Harvard College
RelatedCompanies_xml – name: President and Fellows of Harvard College
Score 3.1079307
Snippet Disclosed herein are botulinum neurotoxin (BoNT) polypeptides with a modified receptor binding domain of Clostridial botulinum serotype B (B-Hc), comprising...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Title ENGINEERED BOTULINUM NEUROTOXIN
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170810&DB=EPODOC&locale=&CC=US&NR=2017226496A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTYyB5Z4KQa6RuampromSSkWukmW5inAPg-w-jNLM0kyBp_E5Otn5hFq4hVhGsHEkAPbCwM-J7QcfDgiMEclA_N7Cbi8LkAMYrmA11YW6ydlAoXy7d1CbF3UoL1jQ3NgDWeg5uJk6xrg7-LvrObsbBsarOYXBJYD7Rm1NHME9pVYQQ1p0En7rmFOoH0pBciVipsgA1sA0Ly8EiEGptQ8YQZOZ9jda8IMHL7QKW8gE5r7ikUY5GGnQLm6KDj5h4T6ePqF-ir4gRbjhfhHePqJMii7uYY4e-gCbYqHeyw-NBjZWcZiDCzALn-qBIOCqYFhcpoxKAMmp5gkGiRbphklmpgnGicaWSSnmlsmSjLI4DNJCr-0NAMXiKsLPthVhoGlpKg0VRZYtZYkyYFDBABmD3gc
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2K12oCSWzDNa5tDEPMi1SYpNpHcQrJJQJBabMS_72RJtKfelh2YnV2YGb7dmW8B7qlEMOIVoiARVRWUvJgJuU4KxDyY_rRKyWXGxOQHmhcrz4ma9OCj64VhPKE_jBwRPYqiv9csXm_-L7FsVlu5fcjfcerz0Y0Mm2_R8ZRghhN52zScZWiHFm9ZRrzig1cma3pGde0JsdIBQVDIwNKb2fSlbHaTinsCh0vUt65PoVeuhzCwur_XhnDkt0_eOGy9b3sGk44FyrE5M4zixTyIfS5oivGiMJkH53DnOpHlCbhS-rexNF7tmiVfQB8hf3kJnCpOaSU3DkgLJROpXkmZQjI5k2a0JHo2gvE-TVf7xRMYeJG_SNHKl2s4bkQCI3kdQ7_--i5vMM3W-S07nV8ocXsG
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ENGINEERED+BOTULINUM+NEUROTOXIN&rft.inventor=Dong+Min&rft.inventor=Peng+Lisheng&rft.inventor=Stenmark+P%C3%A5l+Erik+Gustav&rft.inventor=Berntsson+Ronnie+Per+Arne&rft.date=2017-08-10&rft.externalDBID=A1&rft.externalDocID=US2017226496A1